CoChat

In Silico Analysis Identifies a Novel Role for Androgens in the Regulation of Human Endometrial Apoptosis

Open access
Marshall, Elaine, Lowrey, Jacqueline, MacPherson, Sheila, Maybin, Jacqueline A., Collins, Frances, Critchley, Hilary O. D., Saunders, Philippa T. K. · 2011 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

CONTEXT: The endometrium is a multicellular, steroid-responsive tissue that undergoes dynamic remodeling every menstrual cycle in preparation for implantation and, in absence of pregnancy, menstruation. Androgen receptors are present in the endometrium. OBJECTIVE: The objective of the study was to investigate the impact of androgens on human endometrial stromal cells (hESC). DESIGN: Bioinformatics was used to identify an androgen-regulated gene set and processes associated with their function. Regulation of target genes and impact of androgens on cell function were validated using primary hESC. SETTING: The study was conducted at the University Research Institute. PATIENTS: Endometrium was collected from women with regular menses; tissues were used for recovery of cells, total mRNA, or protein and for immunohistochemistry. RESULTS: A new endometrial androgen target gene set (n = 15) was identified. Bioinformatics revealed 12 of these genes interacted in one pathway and identified an association with control of cell survival. Dynamic androgen-dependent changes in expression of the gene set were detected in hESC with nine significantly down-regulated at 2 and/or 8 h. Treatment of hESC with dihydrotestosterone reduced staurosporine-induced apoptosis and cell migration/proliferation. CONCLUSIONS: Rigorous in silico analysis resulted in identification of a group of androgen-regulated genes expressed in human endometrium. Pathway analysis and functional assays suggest androgen-dependent changes in gene expression may have a significant impact on stromal cell proliferation, migration, and survival. These data provide the platform for further studies on the role of circulatory or local androgens in the regulation of endometrial function and identify androgens as candidates in the pathogenesis of common endometrial disorders including polycystic ovarian syndrome, cancer, and endometriosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2011-0272

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Expression of candidate androgen-regulated gene mRNA in total tissue extracts from human endometrium and decidua as determined by quantitative RT-PCR. Samples were homogenized from functional endometrium recovered during the proliferative (P) and midsecretory phases (MS) as well as from first-trimester decidua (Dec). Concentrations displayed relative to those in proliferative phase in each case (n = 4–6 per group).
Fig. 1. Expression of candidate androgen-regulated gene mRNA in total tissue extracts from human endometrium and decidua as determined by quantitative RT-PCR. Samples were homogenized from functional endometrium recovered during the proliferative (P) and midsecretory phases (MS) as well as from first-trimester decidua (Dec). Concentrations displayed relative to those in proliferative phase in each case (n = 4–6 per group).CC BY-NC · PubMed Central
Fig. 2. Time-dependent changes in androgen-regulated gene expression in primary hESC. Cells were incubated with vehicle (gray bars) or 10−8 m DHT (black bars) for 2, 8, and 24 h (n = 6 each time point). Concentration of mRNA was quantified by quantitative RT-PCR and expressed as fold change compared with time-matched vehicle-treated hESC. Note that with the exception of CD44, incubation of cells with DHT resulted in either a significant reduction in concentration of mRNA or no significant change but with a trend to a reduction. For most genes, changes in mRNA expression were time dependent with the most striking change in total concentrations at 2 h for eight of 12 of the genes. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Fig. 2. Time-dependent changes in androgen-regulated gene expression in primary hESC. Cells were incubated with vehicle (gray bars) or 10−8 m DHT (black bars) for 2, 8, and 24 h (n = 6 each time point). Concentration of mRNA was quantified by quantitative RT-PCR and expressed as fold change compared with time-matched vehicle-treated hESC. Note that with the exception of CD44, incubation of cells with DHT resulted in either a significant reduction in concentration of mRNA or no significant change but with a trend to a reduction. For most genes, changes in mRNA expression were time dependent with the most striking change in total concentrations at 2 h for eight of 12 of the genes. *, P < 0.05; **, P < 0.01; ***, P < 0.001.CC BY-NC · PubMed Central
Fig. 3. Pathway analysis of endometrial androgen target gene set. Note 12 of 15 androgen-regulated genes identified by in silico screening (indicated with multicolored circles) were predicted to interact in a single Metacore pathway centered on AR; intermediate molecules are indicated to show putative intermediate signaling molecules. Key shows the functional classification of the target genes and the arrows indicate predicted regulation (red, negative; green, positive).
Fig. 3. Pathway analysis of endometrial androgen target gene set. Note 12 of 15 androgen-regulated genes identified by in silico screening (indicated with multicolored circles) were predicted to interact in a single Metacore pathway centered on AR; intermediate molecules are indicated to show putative intermediate signaling molecules. Key shows the functional classification of the target genes and the arrows indicate predicted regulation (red, negative; green, positive).CC BY-NC · PubMed Central
Fig. 4. Treatment of hESC with DHT alters apoptosis and proliferation. A, Apoptosis as measured by caspase-3/7 assay in cells treated with staurosporine. Note addition of DHT had a significant impact (*, P < 0.05) on the rate of apoptosis when compared with controls but that the impact of DHT was blunted in the presence of E2 (n = 4). B, Wound-healing assay. Addition of DHT had a significant impact (*, P < 0.05) compared with its vehicle control (ethanol), whereas flutamide alone had no impact compared with vehicle (methanol) and pretreatment of cells with flutamide blocked the DHT-dependent reduction in wound closure. DHT, 10−8 m; flutamide, 10−5 m; n = 6.
Fig. 4. Treatment of hESC with DHT alters apoptosis and proliferation. A, Apoptosis as measured by caspase-3/7 assay in cells treated with staurosporine. Note addition of DHT had a significant impact (*, P < 0.05) on the rate of apoptosis when compared with controls but that the impact of DHT was blunted in the presence of E2 (n = 4). B, Wound-healing assay. Addition of DHT had a significant impact (*, P < 0.05) compared with its vehicle control (ethanol), whereas flutamide alone had no impact compared with vehicle (methanol) and pretreatment of cells with flutamide blocked the DHT-dependent reduction in wound closure. DHT, 10−8 m; flutamide, 10−5 m; n = 6.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 66

Metadata

Authors
Marshall, E., Lowrey, J., MacPherson, S., Maybin, J. A., Collins, F., Critchley, H. O. D., & Saunders, P. T. K.
Affiliations
MRC Centre for Reproductive Health (GB)
Corresponding author
Saunders, Philippa T. K.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2011-11
Volume
96
Issue
11
Pages
E1746-E1755
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2071121000
Cited by
66
References
42
Citations by year
2026: 2 · 2025: 6 · 2024: 3 · 2023: 7 · 2022: 9 · 2021: 5 · 2020: 5 · 2019: 1 · 2018: 2 · 2017: 5 · 2016: 9 · 2015: 2 · 2014: 4 · 2013: 3 · 2012: 3
FWCI
1.99
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
Funders
Wellcome Trust (083908)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
Keywords
androgens, endometrium, endometrial stromal cells, apoptosis, androgen receptor, dihydrotestosterone, cell proliferation, cell migration, cell survival, endometrial function, polycystic ovary syndrome, endometriosis
MeSH terms
Adult, Androgens, Endometrium, Female, Gene Expression Regulation, Humans, Promoter Regions, Genetic, Receptors, Androgen, Stromal Cells, Apoptosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.